Switching to Tirzepatide better than Increasing Dulaglutide Dose in poorly controlled Type 2 Diabetes: Study Dr Riya Dave9 April 2025 9:00 AM ISTResearchers have found in a new research that among patients with poorly controlled type 2 diabetes, switching from dulaglutide to tirzepatide...
Dulaglutide Offers Dual Benefits for Elderly: Improved Blood Sugar Control and Knee OA Pain Relief, Study Finds Medha Baranwal24 Sept 2024 8:00 AM ISTIndia: A recent study has shed light on the dual benefits of dulaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in managing both blood...
How does a diabetes drug lessen symptoms of depression? Dr. Kamal Kant Kohli13 March 2024 11:30 PM ISTResearch in animals has shown that the diabetes drug dulaglutide, which is a glucagon-like peptide-1 (GLP-1) receptor agonist may reduce symptoms of...
Dulaglutide may prevent weight gain after quitting smoking especially among women: BMJ Jacinthlyn Sylvia5 Jan 2024 5:00 PM ISTResearchers have found in a new study that Dulaglutide reduced postcessation weight gain in both genders and was very effective in preventing...
GLP-1 agonists may hasten progression of diabetic retinopathy Dr. Kamal Kant Kohli7 Aug 2023 11:30 AM ISTUSA: Studies have linked the use of GLP-1 receptor agonists with exacerbation of macular disease that frequently occurs in diabetes...
UK probes Novo Nordisk Ozempic, Saxenda over suicidal, self-harming thoughts Ruchika Sharma27 July 2023 2:30 PM ISTLondon: Britain is reviewing a class of drugs used in a diabetes medicine and a weight-loss treatment sold by Novo Nordisk after some patients...
Dulaglutide may prevent diabetic kidney disease in patients with type 2 diabetes Medha Baranwal4 July 2023 11:15 AM ISTUSA: Dulaglutide (DU) may slow the development of diabetic kidney disease in patients with type 2 diabetes (T2D), as indicated by an estimated 25%...
Dulaglutide lowers SBP and pulse pressure independent of weight reduction among diabetes patients Jacinthlyn Sylvia11 April 2023 11:15 AM ISTA new study published in Cardiovascular Diabetology suggests that in all of the placebo-controlled studies conducted as part of the AWARD program,...
Switching from liraglutide to semaglutide leads to weight loss and improves blood sugar control in type 2 diabetes Dr Kartikeya Kohli15 March 2023 11:30 AM ISTJapan: Switching from once-daily liraglutide to once-weekly semaglutide 0.5 mg notably improves blood sugar control and body weight versus switching...
Eli Lilly Gets CDSCO Nod To Study Anti-diabetic Dulaglutide Dr. Divya Colin12 Nov 2022 6:00 PM ISTNew Delhi: Pharmaceutical major, Eli Lilly has got the Subject Expert Committee (SEC) functional under Central Drug Standard Control Organization...
Expanded dulaglutide weekly doses at par with 1.5 mg dose in type 2 diabetes with CVD risk: Study Medha Baranwal14 Sept 2022 10:45 AM ISTUSA: Findings from a post-analysis of the AWARD-11 study have suggested similar favorable effects of dulaglutide 3.0 mg and 4.5 mg on several...
Dulaglutide along with long-acting Insulin yields better results in T2 Diabetics Dr.Niharika Harsha B18 July 2022 1:16 AM ISTDulaglutide in combination with long-acting insulin yielded better blood glucose control than intensive insulin therapy in type 2 diabetics and the...
